RNAC – cartesian therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Cartesian Therapeutics (NASDAQ:RNAC) had its price target raised by analysts at Needham & Company LLC from $40.00 to $42.00. They now have a "buy" rating on the stock.
Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook [Yahoo! Finance]
Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook
Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors [Yahoo! Finance]
Form 144 Cartesian Therapeutics, Filed by: Jewell Christopher M
Form 144 Cartesian Therapeutics, Filed by: Jewell Christopher M
Form 8-K Cartesian Therapeutics, For: Jan 09
Form 4 Cartesian Therapeutics, For: Jan 06 Filed by: Miljkovic Milos
Form 4 Cartesian Therapeutics, For: Jan 06 Filed by: Davis Blaine
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.